Gwynneth Ballentine, PhD MBA
Digital Health Innovation Lead
Gwyn is Digital Health Innovation Lead at the TMC Innovation Institute and works primarily with the TMCx accelerator and Biodesign programs to support and guide current and future companies toward commercial success with their innovative health care products. She also leads engagement of investors with the startup health care companies, as well as with TMC Innovation as a whole.
Gwyn comes to TMC from Diversigen, a Baylor College of Medicine startup company, where she was the director of scientific operations and corporate development. While there, she worked with customers to design and manage projects for optimal results and played a leadership role in identifying strategic opportunities and partnerships that would advance their competitive position in the market. Gwyn has also worked with other startups across various R&D areas, including development of a novel treatment for antibiotic resistant bacterial infections and vaccine development for mosquito borne diseases, where she was successful in raising over $5 million in early stage-funding.
She holds an undergraduate degree in biochemistry from North Carolina State University, and an MBA and a Ph.D. in molecular pathology from Wake Forest University.
She is passionate about startups and the entrepreneurial environment and is eager to commercialize novel technologies in health care.